This study found that coronary artery bypass grafting (CABG) and aortic valve replacement (AVR) are safe for elderly patients, with good outcomes. However, mitral valve replacement (MVR) carries a significantly higher risk in this population.
Area of Science:
Cardiovascular Surgery
Geriatric Medicine
Outcomes Research
Background:
Elderly patients often present with severe heart conditions requiring surgical intervention.
Previous data on the safety and efficacy of cardiac procedures in the elderly population is limited.
High-risk patient profiles necessitate careful evaluation of surgical outcomes.
Purpose of the Study:
To evaluate the safety and outcomes of various cardiac surgical procedures in elderly patients (≥70 years).
To compare the mortality and morbidity associated with aortic valve replacement (AVR), coronary artery bypass grafting (CABG), and mitral valve replacement (MVR) in this age group.
To assess the long-term survival and symptomatic improvement following these procedures.
Main Methods:
Retrospective analysis of 89 patients aged 70-82 years who underwent cardiac procedures between 1955 and the study period.
Procedures included elective and emergency AVR, CABG, combined AVR and CABG, MVR, thoracic aortic aneurysm repair, and other cardiac surgeries.
Data collected included hospital mortality, late deaths, New York Heart Association (NYHA) functional class, and long-term survival rates.
Main Results:
Overall hospital mortality was 18% (16 of 89 patients).
CABG had no early deaths; elective AVR had a 7.7% mortality. Combined AVR/CABG had 10% mortality.
Mitral valve replacement (MVR) demonstrated a significantly high hospital mortality of 57%.
84% of hospital survivors showed symptomatic improvement of at least one NYHA Functional Class.
Conclusions:
Coronary artery bypass grafting (CABG) and aortic valve replacement (AVR) can be performed with acceptable hospital mortality in elderly patients, leading to symptomatic improvement.
Mitral valve replacement (MVR) in elderly patients is associated with an exceptionally high mortality rate, approximately 7.3 times greater than in younger patients.
The high risk of MVR in the elderly necessitates careful consideration and risk-benefit analysis before proceeding with the surgery.